but I think that there's almost certainly other psychedelics that may not even necessarily have to use. And it on microdose, they may simply be less potent, psychedelics that are just as well. If not better suited an example would be a drug that shulgin created called ariadne and Nauticus Boga AR IAD any Also called Alpha, Ethel, to CD, and not a controlled substance. And it was one of a few substances that this kind of Alexander, shulgin created that actually were of interest to pharmaceutical companies. So it was taken through some preclinical research and even given to humans as a potential treatment for dementia and never made it to the market, but it was well before this micro dosing craze began, it was kind of Idea, what if we were to harness some of the mood enhancing properties of psychedelics at low Doses and just make that the therapeutic effect. It may have the pharmacology hasn't been looked at very carefully. So it may actually not be 5H T28 Agonist. It may have some other type of activity, but assuming that it's a low potency 5-ht to a Agonist. That's an example of a drug that isn't being microdose, that produces a microdose type experience, or ibogaine is another one that has really interesting for. Mokou Dynamics, low doses have actually been used as a pharmaceutical and France. It has an energizing effect and you could go on and on there's a lot of these things that are potentially beneficial. So I think that like my major objections to this whole micro dosing thing are the lack of specificity and Precision in the definitions that are used by people. The lack of analytical verification and dosing understanding. And that people are assuming that LSD and psilocybin containing mushrooms are the only two ways to do it. When that's probably just the Of the iceberg.